| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_362d7df142655613551c77e74b6366de |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 |
| filingDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6dc5059ae80896e636d9a9a01d329f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec5e0456d9962a36d20cc26ec7bb903b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e02287e47c07bcc233f04010ecd60a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac1bf0b366884e17200668961a6c4595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc491de8e70a1016d1a46d80339bfe9d |
| publicationDate |
2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IN-2011MU03243-A |
| abstract |
An industrially viable method for the preparation of fludarabine phosphate; wherein debenzylation of 9-(2,3,5-tri-0-berizyl-|3-D-arabinofuranosyl)-2-fluoroadenine intermediate with palladium-charcoal in presence of transfer hydrogenating agent in an organic solvent and further purification of fuldarabine free base in cation exchange resin to pure fludarabine free base and its phosphate salt with pharmaceutically acceptable purity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105859812-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105859812-A |
| priorityDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |